STONKWHISPER
← Back to Intel
Insider ActivityRAPP

Yeleswaram Krishnaswamy, Chief Development Officer at Rapport Therapeutics, Inc., sold $809K of RAPP

Updated Jun 10, 2026
Yeleswaram Krishnaswamy Chief Development Officer
Rapport Therapeutics, Inc. · $RAPP
$809K Total Value
20,225 Shares Traded
$39.9923 Price / Share
246,426 Shares Owned After
2026-04-21 Filing Date

Transaction Details

InsiderYeleswaram Krishnaswamy
TitleChief Development Officer
CompanyRapport Therapeutics, Inc.
TickerRAPP
Transaction TypeSale
Transaction Date2026-04-17
Shares Traded20,225
Price Per Share$39.9923
Total Value$809K
Filed Date2026-04-21
Accession Number0001193125-26-167091

Ownership Context

Shares Owned After Transaction246,426
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-167091

Other Insider Trades — RAPP

Other Trades by Yeleswaram Krishnaswamy

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for RAPP — Rapport Therapeutics, Inc. →

Track RAPP insider activity in real time on The Wire →

Get alerts when Yeleswaram Krishnaswamy files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 10, 2026 at 07:17 UTC

Want real-time data? Access The Wire for live sentiment tracking.